Pharmacogenetics
Pharmacogenetics is a branch of science that explores how genetic variation influences individual responses to medications. It seeks to understand the genetic factors that affect how people metabolize drugs, which can lead to differing effects and side effects among patients. With the increasing emphasis on precision medicine, pharmacogenetics aims to move away from the traditional one-size-fits-all approach to healthcare, advocating for personalized treatment plans that enhance therapeutic effectiveness and minimize adverse reactions.
The foundation of pharmacogenetics lies in the human genome, which consists of approximately 20,000 to 25,000 genes. While most of the human genome is identical among individuals, the small percentage that varies can account for significant differences in drug response. By identifying specific genetic markers linked to these differences, researchers hope to tailor medications to individual genetic profiles.
Despite its promising potential, pharmacogenetics faces challenges, such as the complexity of drug responses influenced by multiple genetic and non-genetic factors. The goal is to develop medications that maximize benefits while minimizing risks, thus improving patient safety and reducing healthcare costs. As this field continues to evolve, it holds the promise of revolutionizing how medications are prescribed and administered, ultimately enhancing patient care.
On this Page
Subject Terms
Pharmacogenetics
Pharmacogenetics is the study of how genes affect the way certain people respond to different medications. In many cases, a person's response to a given medication is determined by his or her inherited genetic makeup. By studying the links between genetics and medicine through pharmacogenetics, physicians can accurately predict what kind of reaction an individual, or even an entire group of people, is likely to have when taking a certain medication. As part of the emerging field of precision medicine, pharmacogenetics is aimed at supporting the development of medications that can be used to treat single patients and larger groups of like patients individually. More broadly, pharmacogenetics is expected to lead the way to a shift from the traditional "one size fits all" approach to medicine to a more individualized plan that will give each patient the best possible chance in the fight against disease with the help of more precisely designed and effective medications.
Background
The history of pharmacogenetics dates back to the 1950s. By that time, scientists understood that a person's genetic makeup was determined by a type of genetic material called deoxyribonucleic acid (DNA) that was found in each of the body's cells. Scientists also understood that genetic differences among individuals were determined by the specific sequence of the chemical bases that make up DNA. To take advantage of this knowledge, however, scientists had to figure out a way to identify what those sequences were.
The first successful attempts to sequence a section of DNA took place in the 1970s. This was only the beginning of a long effort to map the entire human genome, however. The human genome, which refers to all of the genes found within a human being, consists of about 20,000 to 25,000 different genes. As a result, it took scientists decades to sequence the entire genome. Thanks to the creation of improved technology that automated most of the process in the late 1990s, however, scientists were able to successfully sequence the entire human genome in 2003. This accomplishment was a crucial step in the development of pharmacogenetics.
The genetic code is the set of rules by which information found within genetic material is translated into proteins by living cells. The sequential order of the chemical bases that make up DNA tells each cell how to make proteins. The specific proteins produced by cells based on the instructions they receive from DNA ultimately determine a person's genetic traits. While some of these genetic traits translate to physical characteristics such as eye color, others play a role in determining how likely a person is to develop certain diseases.
The proteins produced by DNA are also connected to the effects that medicines have on a person's body. When medications enter a person's system, they come in contact with proteins. The interaction between medications and proteins determines what effect a medication will have on the person taking it. Because each individual's body produces slightly different proteins, one's specific reaction to a given medication may be different than someone else's. Pharmacogenetics is an attempt to understand those differences so treatment methods can be developed that can be personalized for each individual patient.
Overview
People often have different reactions to the same medicine. While many patients may respond positively to a given medication and enjoy improved health when taking it, others may end up suffering painful side effects. Some may even experience a severe reaction to the medication and die as a result of taking it. The type of reaction a person has to a given medication depends in significant part on his or her genetic makeup.
Interestingly, about 99.5 percent of the human genome is identical in all people. Only about 0.5 percent of the genome actually varies from person to person. While this percentage seems quite small, it accounts for millions of differences in the DNA of any two people. These genetic differences determine, among other things, how each person's body will react to a given medication. To identify which genetic variants are responsible for causing disease, scientists compare the genetic makeup of a group of people who have a certain disease with that of people who do not. If a particular genetic variant is present in most of the patients who have a given disease and not present in those who do not have the disease, it can be assumed that the variant in question increases one's risk of developing the disease. Likewise, scientists can look to genetic variations to identify the factors that influence how a person's body will respond to a certain medication. In pharmacogenetics, scientists study genome to identify the genetic factors that determine the body's response to various medications so as to build a better understanding of which medications can be used to most effectively treat disease while minimizing the risk of potential side effects.
Pharmacogenetics could have many beneficial implications for the future of medicine. By allowing for the production of medications that are specifically tailored for individual patients to maximize positive effects and minimize the risk of dangerous side effects, pharmacogenetics may greatly improve patient safety and increase the effectiveness of a wide range of pharmacological treatments. By preventing dangerous side effects, pharmacogenetics may also help to reduce health care costs related to the necessary treatment of such complications. There are, however, some challenges associated with pharmacogenetics. Because drug responses are usually affected by more than one genetic variant, it can be difficult to predict exactly how a person will react to a given medication. Even when a person has a specific variant that is associated with an adverse reaction to a certain medication, there is no guarantee that the person will actually have an adverse reaction when that medication is administered. There are also nongenetic factors that determine how a person's body reacts to medications, further complicating matters. Even when the correct variants can be identified and a pharmacogenetic medication can be produced, that medication must be proven effective and approved by regulatory agencies before it can be made available to the public. Nonetheless, pharmacogenetic medications have great potential and may have an enormously transformative effect on modern medicine.
Bibliography
Drew, Liam. "Pharmacogenetics: The Right Medication for You." Nature, 7 Sept. 2016, www.nature.com/articles/537S60a. Accessed 27 Dec. 2017.
"Frequently Asked Questions about Pharmacogenomics." National Human Genome Research Institute, www.genome.gov/27530645/faq-about-pharmacogenomics. Accessed 27 Dec. 2017.
Khalsa, Soram. "Pharmacogenetics: What It Is and Why You Need to Know." Huffington Post, 28 June 2015, www.huffingtonpost.com/dr-soram-khalsa/pharmacogenetics-what-it-is-‗b‗7683164.html. Accessed 27 Dec. 2017.
"Personalized Medicine and Pharmacogenomics." Mayo Clinic, www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/personalized-medicine/art-20044300?pg=1. Accessed 27 Dec. 2017.
"Pharmacogenetics." National Institute of General Medical Sciences, www.nigms.nih.gov/education/pages/factsheet-pharmacogenomics.aspx. Accessed 27 Dec. 2017.
"Understanding Pharmacogenomics." ASCO Cancer.net, www.cancer.net/navigating-cancer-care/how-cancer-treated/personalized-and-targeted-therapies/understanding-pharmacogenomics. Accessed 27 Dec. 2017.
"What Is Pharmacogenomics?" SpineUniverse, www.spineuniverse.com/treatments/medication/what-pharmacogenetics. Accessed 27 Dec. 2017.
"What Is Pharmacogenomics?" YourGenome.org, www.yourgenome.org/facts/what-is-pharmacogenomics. Accessed 27 Dec. 2017.